ViiV Healthcare Medical Pipeline
1

Binding and Fusion

VH3810109
Class: bNAb
Phase: II

VH4527079
Phase: I

2

Nuclear Entry & Uncoating

VH400280
Class: Capsid Inhibitor
Phase: II

VH4011499
Class: Capsid Inhibitor
Phase: I

3

Integration

Cabotegravir – New formulations
Class: INSTI
Phase: I

VH4524184
Class: INSTI
Phase: I

VH4367310
Phase: I

4

Assembly and Budding

VH400280
Class: Capsid Inhibitor
Phase: II

VH4011499
Class: Capsid Inhibitor
Phase: I

5

Maturation

VH3739937
Class: Maturation Inhibitor
Phase: I

OUR PIPELINE

1 2 3 4 5
Pipeline image 00
Pipeline image 01
1

Binding and Fusion

VH3810109
Class: bNAb
Phase: II

VH4527079
Phase: I

Pipeline image 02
2

Nuclear Entry & Uncoating

VH400280
Class: Capsid Inhibitor
Phase: II

VH4011499
Class: Capsid Inhibitor
Phase: I

Pipeline image 03
3

Integration

Cabotegravir – New formulations
Class: INSTI
Phase: I

VH4524184
Class: INSTI
Phase: I

VH4367310
Phase: I

Pipeline image 04
4

Assembly and Budding

VH400280
Class: Capsid Inhibitor
Phase: II

VH4011499
Class: Capsid Inhibitor
Phase: I

Pipeline image 05
5

Maturation

VH3739937
Class: Maturation Inhibitor
Phase: I

Are you a US healthcare provider?

This web portal is intended as an educational resource for healthcare providers practicing in the United States. It may include information about products or uses that have not been approved by the US Food and Drug Administration.

If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse.

Connect With Our Medical Experts

Find My ViiV MSL

Easily find the ViiV Medical Science Liaison (MSL) in your area.

Talk to a Medical Expert

Connect now with a live ViiV Medical Expert.

Request a Scientific Discussion

Submit a request for additional information from a ViiV Medical Expert.

Contact Us

Chat Live

Get immediate assistance from a ViiV Healthcare Professional.

Call 1‑888‑226‑8434

Weekdays from 8 AM to 6 PM ET
(5 AM – 3 PM PT)

Report an Adverse Event

To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at 1‑877‑844‑8872 or FDA at 1‑800‑332‑1088 or www.fda.gov/medwatch